MeSH D012507 - sarcoidosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cortisone | Cortisone |  | 1982-01-01 |  |  |
| Dexamethasone | Dexamethasone |  | 1990-08-31 |  |  | |
| Methylprednisolone | Methylprednisolone |  | 2006-10-27 |  |  | |
| Prednisolone | Prednisolone |  | 1999-05-28 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Prednisolone | Prelone |  | 1986-02-04 |  |  | |
| Novast Laboratories | Methylprednisolone | Methylprednisolone |  | 2019-01-09 |  |  |
| Padagis | Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2022-02-11 |  |  | |
| Taro Pharmaceutical | Prednisolone | Flo-pred | 2028-10-11 | 2008-01-17 |  |  |
| Mylan | Dexamethasone | Dexamethasone |  | 2008-08-29 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Sandoz | Dexamethasone | Dexamethasone |  | 1985-01-16 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  | |
| Methylprednisolone | Methylprednisolone |  | 1997-10-31 |  |  | |
| Dexamethasone, Ciprofloxacin | Ciprodex | 2025-06-04 | 2003-07-18 |  |  | |
| Prednisolone | Omnipred |  | 1982-01-01 |  |  | |
| Dexamethasone, Tobramycin | Tobradex |  | 1988-08-18 |  |  | |
| AiPing Pharmaceutical | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Genus Lifesciences | Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1993-05-27 |  |  |
| Organon | Methylprednisolone | Methylprednisolone |  | 1982-06-25 |  |  |
| AbbVie | Dexamethasone | Ozurdex | 2023-01-09 | 2009-06-17 | $486 M | Q2/24-Q1/25 |
| Prednisolone | Pred |  | 1982-01-01 |  |  | |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
33%2/6
Phase 2
29%8/28
Phase 3
64%14/22
Approved: 7Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use